NOD-SCID Mice
Showing 1 - 25 of 890
Acute-On-Chronic Liver Failure Trial in Beijing (standard medical treatment, hUC-MSC at week0, Placebo at week0)
Not yet recruiting
- Acute-On-Chronic Liver Failure
- standard medical treatment
- +10 more
-
Beijing, Beijing, Chinathe Fifth Medical Center, Chinese PLA General Hospital
Aug 15, 2023
Ovarian Cancer Stage IV Trial in France (Pembrolizumab Injectable Product - Chemotherapy - Bevacizumab, Chemotherapy -
Active, not recruiting
- Ovarian Cancer Stage IV
- Pembrolizumab Injectable Product - Chemotherapy - Bevacizumab
- Chemotherapy - Bevacizumab
-
Avignon, France
- +16 more
Feb 15, 2022
Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and
Recruiting
- Granuloma
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Hematological Malignancies Trial in Bologna (Intrabone cord blood infusion)
Completed
- Hematological Malignancies
- Intrabone cord blood infusion
-
Bologna, ItalyHematology Institute "L. and A. Seràgnoli", S. Orsola-Malpighi U
Mar 18, 2021
The Cranio-cervical Flexion Test Using the NOD Device
Not yet recruiting
- Muscle Strength
- +3 more
- cranio-cervical flexion test with NOD
-
Winterthur, SwitzerlandZurich University of applied sciences
Sep 7, 2023
Severe Combined Immunodeficiency Trial in San Francisco (AProArt, CliniMACS® CD34 Reagent System cell sorter device, Busulfan)
Recruiting
- Severe Combined Immunodeficiency
- AProArt
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco (UCSF) Children's Hospit
Feb 4, 2022
COVID-19 Respiratory Infection, Influenza Trial in Tucson (COVID-19 Vaccine)
Recruiting
- COVID-19 Respiratory Infection
- Influenza
- COVID-19 Vaccine
-
Tucson, ArizonaUniversity of Arizona
Sep 28, 2021
Severe Combined Immunodeficiency Disease, X-linked Trial in San Francisco, Memphis, Seattle (genetic, drug, device)
Recruiting
- Severe Combined Immunodeficiency Disease, X-linked
- CL20-i4-EF1α-hγc-OPT
- +2 more
-
San Francisco, California
- +2 more
Jan 9, 2023
Genetic Basis of Immunodeficiency
Recruiting
- Severe Combined Immunodeficiency
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 21, 2023
Multiple Myeloma Trial in Ann Arbor (Iodine I 131 Tositumomab)
Active, not recruiting
- Multiple Myeloma
- Iodine I 131 Tositumomab
-
Ann Arbor, MichiganUniversity of Michigan
Mar 16, 2022
Next Generation " Pre-clinical Model for Colorectal Cancer
Recruiting
- Colorectal Cancer Metastases and Hepatocellular Carcinomas
- Tumor /metastases removal
-
Marseille, Franceap-HM hopital nord
May 17, 2022
Severe Combined Immunodeficiency, X-Linked Trial in London (Lentiviral vector transduced CD34+ cells)
Recruiting
- Severe Combined Immunodeficiency, X-Linked
- Lentiviral vector transduced CD34+ cells
-
London, Greater London, United KingdomGreat Ormond Street Hospital for Children NHS Foundation Trust
Mar 15, 2022
The Experience of Screening for SCID
Recruiting
- Severe Combined Immunodeficiency
- SCID Screening
-
London, United KingdomKing's College London
Dec 6, 2022
Depressive Disorder Trial in Tanta (Fluoxetine 20 mg, Dapagliflozin 10mg Tab, Atorvastatin 80mg)
Not yet recruiting
- Depressive Disorder
- Fluoxetine 20 mg
- +2 more
-
Tanta, Shebeen El-Kom, EgyptFaculty of Medicine, Menoufia University
Mar 19, 2023
Kintsugi Voice Device Study
Recruiting
- Depression, Anxiety
- Kintsugi Voice Device
-
Berkeley, CaliforniaKintsugi Mindful Wellness, Inc.
Sep 27, 2022
Neonatal Screening of Severe Combined Immunodeficiencies
Completed
- Severe Combined Immunodeficiency
- Neonatal Screening
-
Shanghai, Shanghai, ChinaChildren's Hospital of Fudan University
Jan 3, 2022
Artemis (DCLRE1C ) Deficient Severe Combined Immunodeficiency Trial in Paris (ARTEGENE drug product)
Not yet recruiting
- Artemis (DCLRE1C ) Deficient Severe Combined Immunodeficiency
- ARTEGENE drug product
-
Paris, FranceDepartment of Pediatric Immunology, Hematology and Rheumatology
Sep 26, 2022
Memory CD8+ T Cells With Sepsis Severity and
Recruiting
- Sepsis
- Inflammatory Response
-
Wuhan, Hubei, ChinaDepartment of Critical Care Medicine, Union Hospital, Tongji Med
May 16, 2023
Type 1 Diabetes Trial in Milan (Sitagliptin, Professional CGM)
Not yet recruiting
- Type 1 Diabetes
- Sitagliptin
- Professional CGM
-
Milan, ItalyASST FBF Sacco
Jun 14, 2022
Preeclampsia, Labor, Premature Trial in Columbus (Monoket Pill, Placebo)
Completed
- Preeclampsia
- Labor, Premature
- Monoket Pill
- Placebo
-
Columbus, OhioThe Ohio State Medical Center Labor and Delivery Unit
Dec 7, 2021
X-linked Severe Combined Immunodeficiency Trial in Paris (Gene transfer)
Completed
- X-linked Severe Combined Immunodeficiency
- Gene transfer
-
Paris, FranceHopital Necker
Sep 22, 2021
Severe Combined Immunodeficiency Due to RAG1 Deficiency Trial in Leiden (Gene therapy)
Recruiting
- Severe Combined Immunodeficiency Due to RAG1 Deficiency
- Gene therapy
-
Leiden, NetherlandsLeiden University Medical Center
Dec 3, 2021
Physical Inactivity, Phosphate Overload, Visceral Obesity Trial (Sodium Phosphate, Sodium Chloride)
Not yet recruiting
- Physical Inactivity
- +2 more
- Sodium Phosphate
- Sodium Chloride
- (no location specified)
Aug 5, 2022
Decoding the Genetic Landscape of Skeletal Diseases
Recruiting
- Genetic Skeletal Diseases
- +3 more
-
Stockholm, SwedenKarolinska University Hospital
May 16, 2023
Cholesterol Variability, Trained Immunity Trial (Atorvastatin)
Not yet recruiting
- Cholesterol Variability
- Trained Immunity
- (no location specified)
Mar 17, 2023